What Researchers Did
Researchers conducted a prospective pre-post cohort study to investigate the impact of hyperbaric oxygen therapy (HBOT) on endometrial growth and pregnancy outcomes in patients with resistant thin endometrium undergoing frozen embryo transfer (FET).
What They Found
The provided abstract did not include the specific findings regarding endometrial thickness or pregnancy outcomes after hyperbaric oxygen therapy. Therefore, numerical results from this study cannot be reported here.
What This Means for Canadian Patients
If future complete studies confirm the efficacy of hyperbaric oxygen therapy for resistant thin endometrium, it could potentially offer a new treatment option for Canadian patients undergoing frozen embryo transfer. This might improve implantation rates and pregnancy outcomes for those who have not responded to conventional therapies.
Canadian Relevance
This study was not conducted in Canada and has no direct Canadian connection.
Study Limitations
A limitation of this study is the voluntary assignment of patients to treatment groups, which could introduce selection bias despite propensity score matching.